There could be an upside to incorporating AI for the FDA. Using AI to assist in final drug reviews would "represent a chance ...

Thoughts of suicide was confirmed as a side effect of finasteride (Propecia, Proscar), the European Medicines Agency (EMA) ...

WASHINGTON — FDA Commissioner Martin Makary offered more details into the agency’s recently announced plans to place ...

Read about the move to scale use of AI across all FDA centers by the end of June and learn more about future plans to expand ...

The FDA has started exploring how AI can be used to accelerate drug approvals in collaboration with OpenAI amid oversight ...

The unintentional theme of today’s issue is the struggle for control over how we implement AI in the U.S. On one side, where ...

The FDA  plans to launch generative AI across all of its centers by June 30. The agency has also appointed its first chief AI ...

FDA's plan to deploy an AI tool to assist with scientific review process raises questions about transparency and risks.

Commissioner Martin Makary also said the agency would roll out a generative AI system across its centers that will help FDA ...

In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

The FDA expects to fully integrate its AI approach by June 30, though its different centers have been instructed to start the ...

Stuart J. Schnitt, MD, discussed how AI enhances cancer diagnoses and the need for professional oversight, ethical clarity, ...